It's never easy being a snitch and a new study in The New England Journal of Medicine finds the process takes a heavy toll on personal and professional lives, since whistleblower cases last, on average, almost five years. The researchers interviewed 26 people who filed 17 cases against drugmakers from January 2001 to March 2009, and the whistleblowers received shares of settlements ranging from $100,000 to $42 million - an average of $3 million.
- Enjoy this article? Help vote it up the 'Vine.
- Public Discussion (1)
What motivated them? The most common reply was integrity.
Add to that-ETHICS-something the pharma industry sorely lacking.
You're in Easy Mode. If you prefer, you can use XHTML Mode instead. |
As a new user, you may notice a few temporary content restrictions. Click here for more info.



